Specialty Pharma Journal Specialty, Precision & Technology
WASHINGTON, June 5, 2018 /PRNewswire/ — Researchers at Exact Sciences Corp. (Nasdaq: EXAS) and Mayo Clinic announced significant progress toward developing a panel of novel, blood-based, DNA biomarkers that could accurately detect hepatocellular carcinoma (HCC), the most common cancer that originates in the liver.1 The researchers detailed their findings during …
Tag Archives: Mayo Clinic
June, 2018
May, 2018
-
24 May
Cytox and Mayo Clinic Collaborate to Evaluate Novel Genetic Based Approaches for Assessing Alzheimer’s Risk
OXFORD, England & MANCHESTER, England–(BUSINESS WIRE)–Cytox, a precision medicine front-runner which today is commercializing polygenic risk scoring (PRS) approaches for assessing genetic risk for developing Alzheimer’s and other neurological diseases, has announced it has entered into a research collaboration with Mayo Clinic to test current and develop new proprietary algorithms …
January, 2018
-
31 January
SkylineDx and Mayo Clinic Enter Strategic Collaboration to Develop Diagnostic Tests for Melanoma
ROTTERDAM, Netherlands, Jan. 31, 2018 /PRNewswire/ — SkylineDx today announced a strategic collaboration with Mayo Clinic to develop novel diagnostic tests which will improve clinical decision making for melanoma patients. For SkylineDx, the collaboration with the renowned Mayo Clinic is an important milestone as it allows the company to develop …
September, 2017
-
1 September
Mayo Clinic Researchers Identify Genes Fueling Neuroblastoma Spread
ROCHESTER, Minn. — For the first time, Mayo Clinic researchers and colleagues present data on how nervous system tumors, called neuroblastomas, spread. Their paper, published in Cancer Cell, clarifies the relationship between two genes that fuel the aggressive spread of neuroblastomas. Neuroblastoma is a cancer that most commonly affects children age …
May, 2017
-
31 May
Baxter and Mayo Collaborate to Transform Patient Care
DEERFIELD, Ill. & JACKSONVILLE, Fla.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a global medical products company, and Mayo Clinic today announced a new research and development collaboration to advance innovation across a spectrum of therapeutic areas where there are high unmet patient needs. The collaboration agreement will bring together the clinical and …
January, 2017
-
9 January
Mayo Clinic Research Identifies Potential New Treatment for Breast Cancer Metastasis
ROCHESTER, Minn. — Breast cancer metastasis, the process by which cancer spreads, may be prevented through the new use of a class of drugs already approved by the U.S. Food and Drug Administration. Mayo Clinic researchers have identified that a key drug target, CDK4/6, regulates a cancer metastasis protein, SNAIL, …
November, 2016
-
11 November
Illumina and Mayo Clinic Form Bioinformatics Relationship to Advance Genetic Disorder Testing
SAN DIEGO & ROCHESTER, Minn.–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced it has entered an agreement with Mayo Clinic to make advancements in next-generation sequencing technology with the intent to accelerate Mayo’s delivery of genetic and genomic expertise. Together, the organizations plan to integrate existing services and software tools and …
June, 2016
-
24 June
Mayo Clinic Introduces Precision Medicine in Psychiatry
ROCHESTER, Minn. — Mayo Clinic is highlighting the potential merits of using precision medicine in prescribing antidepressants. Details appear in the current issue of Mayo Clinic Proceedings. Eleven percent of Americans 12 years and older have been prescribed antidepressant medication, according to Centers for Disease Control and Prevention data from …
February, 2016
-
3 February
Morphotek and Mayo Clinic Partner to Study Diagnostic Assays in Triple-Negative Breast Cancer
EXTON, Pa., Feb. 3, 2016 /PRNewswire/ — Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that it is collaborating with researchers Keith L. Knutson, Ph.D. in the Department of Immunology and Edith A. Perez, M.D. in the Department of Hematology and Oncology at Mayo Clinic in Jacksonville, Florida in a …
January, 2016
-
27 January
Researchers Find Smokers Who Quit More than 15 Years Ago Need Screening
ROCHESTER, Minn. — Expanding lung cancer screening to include people who quit smoking more than 15 years ago could detect more cases and further reduce associated mortality, according to a study by Mayo Clinic researchers published in the Journal of Thoracic Oncology. “A decline in smoking rates has been, and continues to …